Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BMRN | INSM | TECH | ||
| Company | Biomarin Pharmaceuticals | Insmed Inc | Bio-Techne Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 62.40 | 73.12 | 68.60 | ||
| High | 63.76 | 74.09 | 71.32 | ||
| Low | 61.41 | 70.93 | 68.42 | ||
| Last | 63.45 | 73.81 | 71.05 | ||
| Change | +0.89 | +1.14 | +2.33 | ||
| % Change | +1.42% | +1.57% | +3.39% | ||
| Volume | 1,362,600 | 1,373,700 | 1,338,400 | ||
| 20-Day Average Volume | 1,595,015 | 1,646,195 | 1,229,690 | ||
| Previous Close | 62.56 | 72.67 | 68.72 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 65.96 | 70.61 | 72.74 | ||
| 20-Day Raw Stochastic | 23.40% | 94.61% | 35.81% | ||
| 20-Day Relative Strength | 33.37% | 53.63% | 47.11% | ||
| Weighted Alpha | -33.68 | +42.88 | +4.17 | ||
| Today's Opinion | 100% Sell | 40% Buy | 72% Sell | ||
| Previous Opinion | 100% Sell | 24% Buy | 72% Sell | ||
| Last Month's Opinion | 88% Sell | 56% Buy | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.28% since 11/14/24 | +3.58% since 11/14/24 | -2.05% since 11/14/24 | ||
| Low | 61.15 on 11/19/24 | 64.86 on 11/18/24 | 65.61 on 11/20/24 | ||
| High | 66.05 on 11/15/24 | 74.09 on 11/21/24 | 72.46 on 11/15/24 | ||
| 1-Month | |||||
| %Chg | -9.72% since 10/21/24 | +2.12% since 10/21/24 | +0.98% since 10/21/24 | ||
| Low | 61.15 on 11/19/24 | 64.86 on 11/18/24 | 65.61 on 11/20/24 | ||
| High | 70.98 on 10/25/24 | 74.32 on 11/14/24 | 80.80 on 11/06/24 | ||
| 3-Month | |||||
| %Chg | -31.46% since 08/21/24 | -4.16% since 08/21/24 | -2.20% since 08/21/24 | ||
| Low | 61.15 on 11/19/24 | 64.86 on 11/18/24 | 65.61 on 11/20/24 | ||
| High | 93.04 on 08/29/24 | 80.53 on 08/22/24 | 80.95 on 09/19/24 | ||
| 6-Month | |||||
| %Chg | -17.96% since 05/21/24 | +200.90% since 05/21/24 | -14.07% since 05/21/24 | ||
| Low | 61.15 on 11/19/24 | 21.92 on 05/24/24 | 65.61 on 11/20/24 | ||
| High | 94.85 on 08/20/24 | 80.53 on 08/22/24 | 83.96 on 05/23/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 11,922,872 | 13,000,880 | 10,919,058 | ||
| Shares Outstanding, K | 190,583 | 178,903 | 158,892 | ||
| Annual Sales | 2,419,230,000 | 305,210,000 | 1,159,060,000 | ||
| Annual Net Income | 167,650,000 | -749,570,000 | 168,110,000 | ||
| Last Quarter Sales | 745,740,000 | 93,430,000 | 289,460,000 | ||
| Last Quarter Net Income | 106,080,000 | -220,520,000 | 33,600,000 | ||
| 60-Month Beta | 0.31 | 1.12 | 1.28 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.91 on 10/29/24 | -1.27 on 10/31/24 | 0.42 on 10/30/24 | ||
| Latest Earnings Date | 10/29/24 | 10/31/24 | 10/30/24 | ||
| Most Recent Dividend | N/A | N/A | 0.080 on 11/08/24 | ||
| Next Ex-Dividends Date | N/A | N/A | 11/08/24 | ||
| Ratios | |||||
| Price/Earnings ttm | 27.42 | 0.00 | 40.72 | ||